Nida data, statistics, and clinical trial support center. N01DA-19-2250. Base award.

Ended Indefinite Delivery Contract Awarded Last action

Contract number
75N95019D00013
Awardee
Awarding agency
Task orders
26 $32,639,546 obligated

Award facts

Opportunity
  • 75N95019R00016 Solicitation number
Combined order value
$32,639,546 Current and potential, with all options
Last date to order 100% complete
IDV ceiling 98% used
$33,253,342.00
Maximum order
$33,253,342.00
Award type
Single award
Who can order
Only the awarding agency
Set-aside
No set-aside
Competition
Full and Open Competition · 4 offers Negotiated Proposal / Quote
Pricing
Order Dependent (IDV only)
Legislative mandates

Award details come from SAM.gov/FPDS.

About this IDV

Written by GovTribe AI ·

The National Institutes of Health National Institute on Drug Abuse (NIDA) awarded a single-award indefinite delivery contract to The Emmes Company LLC, a global clinical research organization, to provide a range of data, statistics, and clinical trial support services in support of NIDA's mission. The contract has a potential value of $33,253,342.

Under this IDV, The Emmes Company LLC has been issued multiple task orders to provide specialized services such as data coordination, statistical analysis, clinical trial management, and data safety monitoring board support for a portfolio of NIDA-funded studies and initiatives. These include studies focused on addressing the opioid crisis, integrating pharmacists into medication treatment for opioid use disorder, conducting longitudinal follow-up of individuals with opioid use disorder, and supporting NIDA's Helping to End Addiction Long-Term (HEAL) Initiative. The work is predominantly performed at The Emmes Company's facility in Potomac, Maryland, with no subcontractors or set-aside designations indicated across the various task orders.

Task orders

Task order Ordering agency Obligated Awarded
Management of unhealthy opioid and polysubstance use among patients in primary care setting. 09/01/2022 - 08/14/2027… 75N95022F00002 National Institute on Drug Abuse (NIH) $1,249,861
Nida data, statistics, and clinical trial support center management and support. 03/01/2022 - 02/28/2023… 75N95022F00001 National Institute on Drug Abuse (NIH) $1,380,677
Longitudinal follow-up of individuals with opioid use disorder (LFU-OUD). 09/01/2021 - 08/31/2026. N01DA-19-2250… 75N95021F00007 National Institute on Drug Abuse (NIH) $1,822,096
DSC management and support for helping to end addiction long-term initiative (heal). 9/1/2021-8/31/2022. N01DA-19-2250… 75N95021F00005 National Institute on Drug Abuse (NIH) $2,419,237
Pharmacist-integrated model of medication treatment for opioid use disorder (CTN-0116). 09/01/2021 - 03/01/2024… 75N95021F00006 National Institute on Drug Abuse (NIH) $686,833
Nida data, statistics, and clinical trial support center management and support. 07/01/2021 - 6/14/2024. N01DA-19-2250… 75N95021F00004 National Institute on Drug Abuse (NIH) $1,337,939
Nida data, statistics, and clinical trial support center management and support. 07/01/2021 - 10/30/2023… 75N95021F00003 National Institute on Drug Abuse (NIH) $1,149,960
Nida data, statistics, and clinical trial support center dsmb management and support. 03/01/2021 - 02/28/2022… 75N95021F00002 National Institute on Drug Abuse (NIH) $9,506
Nida data, statistics, and clinical trial support center management and support. 03/01/2021 - 02/28/2022… 75N95021F00001 National Institute on Drug Abuse (NIH) $1,087,752
Transcranial magnetic stimulation for the treatment of methamphetamine/cocaine use disorder (CTN-0108)… 75N95020F00007 National Institute on Drug Abuse (NIH) $806,041
DSC management and support for helping to end addiction long-term initiative (heal). 9/21/2020-9/20/2021… 75N95020F00008 National Institute on Drug Abuse (NIH) $1,285,018
Integrating pharmacy-based prevention & treatment of opioid & other substance use disorders: a survey of pharmacists… 75N95020F00005 National Institute on Drug Abuse (NIH) $347,989
Primary care opioid use disorders treatment trial (CTN-0074). 9/1/2020 - 12/31/2021. N01DA-19-2250. Task order… 75N95020F00004 National Institute on Drug Abuse (NIH) $215,776
Peer intervention to link overdose survivors to treatment (CTN-0107). 9/1/2020-7/3/2023. N01DA-19-2250. Task order… 75N95020F00006 National Institute on Drug Abuse (NIH) $799,161
Adolescent screening to help eliminate misuse (CTN-0060-a-1). 8/1/2020 - 12/31/2021. N01DA-19-2250. Task order… 75N95020F00003 National Institute on Drug Abuse (NIH) $200,105
Optimizing retention, duration & discontinuation strategies for opioid use disorder pharmacotherapy (CTN-0100)… 75N95020F00002 National Institute on Drug Abuse (NIH) $3,122,596
Nida data, statistics, and clinical trial support center management and support. 03/01/2020 - 02/28/2021… 75N95020F00001 National Institute on Drug Abuse (NIH) $2,645,396
Rural expansion of medications for opioid use disorder (CTN-0102). DSC5 contract. 09/20/2019 - 05/15/2023… 75N95019F00098 National Institute on Drug Abuse (NIH) $1,614,088
Subthreshold opioid use disorder prevention trial (CTN-0101). DSC5 contract. 09/20/2019 - 11/16/2020. N01DA-19-2250. 75N95019F00097 National Institute on Drug Abuse (NIH) $1,884,166
Emergency department-initiated buprenorphine and validation network trial (CTN-0099). DSC5 contract. 09/20/2019… 75N95019F00095 National Institute on Drug Abuse (NIH) $2,152,020
Ancillary study of the adoption and sustainability of ED-initiated buprenorphine (CTN-0079-a-1). DSC5 contract… 75N95019F00089 National Institute on Drug Abuse (NIH) $789,585
Clinic-randomized trial of clinical decision support for opioid use disorders in medical settings (CTN-0095). DSC5… 75N95019F00091 National Institute on Drug Abuse (NIH) $881,366
Culturally centered treatment for OUD implementation for addiction treatment programs serving american indian/alaska… 75N95019F00092 National Institute on Drug Abuse (NIH) $511,983
Exemplar hospital initiation trial to enhance treatment engagement (CTN-0098). DSC5 contract. 09/20/2019… 75N95019F00094 National Institute on Drug Abuse (NIH) $2,030,956
Surmounting withdrawal to initiate fast treatment with naltrexone (CTN-0097). DSC5 contract. 09/20/2019 - 11/23/2021… 75N95019F00093 National Institute on Drug Abuse (NIH) $1,251,569
Nida data, statistics, and clinical trial support center. 09/01/2019 - 02/29/2020. N01DA-19-2250. Task order no 01. 75N95019F00088 National Institute on Drug Abuse (NIH) $957,870
Show all 26

Transactions

Action Obligated Date
Other Administrative Action P00005 · Alternate COR. Nida data, statistics, and clinical trial support center. September 1, 2019 to august 31, 2022. N01DA-19-2250. $0
Other Administrative Action P00004 $0
Other Administrative Action P00003 · Nida data, statistics, and clinical trial support center. September 1, 2019 to august 31, 2022. N01DA-19-2250. $0
Other Administrative Action P00002 $0
Change Order P00001 · Nida data, statistics, and clinical trial support center. September 1, 2019 to august 31, 2022. N01DA-19-2250. $0
Original award $0

Quick answers

Who was awarded contract 75N95019D00013?

75N95019D00013 was awarded to The Emmes Company, LLC by National Institute on Drug Abuse (National Institutes of Health) on September 1, 2019.

How much is contract 75N95019D00013 worth?

Orders under 75N95019D00013 have obligated $32,639,546. 75N95019D00013's own ceiling is $33,253,342. A single order can be worth up to $33,253,342.

How many orders have been placed under contract 75N95019D00013?

26 orders have been placed under 75N95019D00013, the latest on September 1, 2022.

Who can order from contract 75N95019D00013?

75N95019D00013 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.

Was contract 75N95019D00013 competed?

The extent of competition for 75N95019D00013 was full and open competition. The government received 4 offers.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV
Try for free Login